Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Looks to Auction Off Genomics-Related Items

NEW YORK, May 17 (GenomeWeb News) - As part of its ongoing transition from a genomics company to a pharmaceutical firm, Incyte hopes to auction off many of its genomic research and laboratory equipment, GenomeWeb News has learned.

 

DoveBid, a capital asset auction and valuation company, has reported on its website that it will hold a webcast auction of various Incyte assets deemed "surplus to [the company's] continuing operations."

 

Among the items up for sale are a Cytomation S-1312 MoFlo high performance cell sorter, centrifuges, ultracentrifuges, and automatic pipetors, said DoveBid.

 

The auction will be held on June 15 at 9 a.m. Pacific Daylight Time. Details about the event can be found at here.

 

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.